AVENUE THERAPEUTICS INC - COM (ATXI)

CUSIP: 05360L304

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / COM
Total 13F shares
324,311
Share change
+101,691
Total reported value
$52,443
Price per share
$0.16
Number of holders
14
Value change
-$19,092
Number of buys
7
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 05360L304?
CUSIP 05360L304 identifies ATXI - AVENUE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AVENUE THERAPEUTICS INC - COM (ATXI) as of Q4 2023

As of 31 Dec 2023, AVENUE THERAPEUTICS INC - COM (ATXI) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 324,311 shares. The largest 10 holders included CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, TWO SIGMA SECURITIES, LLC, HRT FINANCIAL LP, Cubist Systematic Strategies, LLC, Tower Research Capital LLC (TRC), and WELLS FARGO & COMPANY/MN. This page lists 14 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.